Neuronetics Company
Neuronetics develops non-invasive therapies for psychiatric and neurological disorders.
Headquarters:
Malvern, Pennsylvania, United States
Total Funding:
248400000
Founded Date:
2003
Investors Number:
15
Estimated Revenue:
$10M to $50M
Last Funding Date:
2021
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exists:
N/A
Technology:
Neuromodulation
Employee Number:
101-250
Industry:
Biotechnology, Health Care, Medical Device, Therapeutics
Last Funding Type:
Post-IPO Equity
Funding Status:
IPO